Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 203985 / DOSAGE - TABLET, FOR SUSPENSION;ORAL - 5MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| EVEROLIMUS(UNII: 9HW64Q8G6G) (EVEROLIMUS - UNII:9HW64Q8G6G) | EVEROLIMUS | 7.5mg | 2mg | 3mg | 10mg | 2.5mg | 5mg | 5mg |
Inactive Ingredients
| Ingredient Name | Novartis Pharmaceuticals Corporation |
|---|---|
| ANHYDROUS LACTOSE(3SY5LH9PMK) | |
| BUTYLATED HYDROXYTOLUENE(1P9D0Z171K) | |
| CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | |
| CROSPOVIDONE(68401960MK) | |
| HYPROMELLOSES(3NXW29V3WO) | |
| LACTOSE MONOHYDRATE(EWQ57Q8I5X) | |
| MAGNESIUM STEARATE(70097M6I30) | |
| MANNITOL(3OWL53L36A) | |
| SILICON DIOXIDE(ETJ7Z6XBU4) |
